FDA 483 - Exel Inc. d/b/a DHL Supply Chain - March 13, 2020

Exel Inc. d/b/a DHL Supply Chain in Manchester, PA, a drug repacker/relabeler, received a Form 483 with two observations. The inspection revealed that the firm failed to thoroughly investigate unexplained discrepancies related to incorrect drug quantities in distributed products. Additionally, the firm did not conduct GMP training with sufficient frequency for employees involved in repacking and relabeling operations.